Tower in Dubai catches fire
No injuries have been reported thus far.
Pfizer Snags Hospira in $16 Billion Deal
Okay. It's Thursday February 5 the markets in New York are open and our big number this morning sixteen billion. That amounts pharma giant Pfizer is going to pay for Hospira maker of injectable drugs. Pfizer's bid of 98 dollars a share is a whopping 39% premium to yesterday's closing price. Pfizer
Rents Slashed in America's Tallest Building
Morning Money Memo: New York City’s giant World Trade Center is supposed to be a bold symbol of revival for Lower Manhattan in the years after the 9/11 attacks. But the owners of the building are slashing rents by nearly 10 percent because they can’t...
The Social Climber: Amber Rose Wears Epic Shades
Amber Rose Wears Epic Shades, Ric Flair's Daughter Enters the Wrestling Ring
Consumer Uproar Over AT&T Bid for DirecTV
Morning Money Memo… Consumer groups are in full cry against the proposed takeover of satellite TV company DirecTV by AT&T. “That’s not good for consumers,” says Craig Aaron, president of the non-profit media and technology advocacy group, Free Press. “Their prices end up going up...
New TV Merger? AT&T Mulling Bid $50B for DirecTV
Morning Money Memo…. Streaming TV is a huge growth industry and that may the main reason why AT&T may be willing to buy DirecTV for more than $50 billion. The proposed takeover would be the latest merger in the pay-TV, giving AT&T, the second largest...
Pfizer Fizzles: Drug Company Has Rough First Quarter
The drug maker sees revenue drop 9 percent and income down 15 percent since 2013.
US Hiring Jumps but the Right Skills in Short Supply
Morning Money Memo: The jobs market shook off the winter chills, and showed clear signs of improvement last month. The U.S. unemployment rate dropped to 6.3 percent from 6.7 percent, the lowest in more than five years. The Labor Department says employers added 288,000, the...
2014 Takeover Deals Cross Trillion Dollar Threshold
This year's total mergers and acquisitions reach milestone at the fastest pace in seven years.
Pharmaceuticals Still in Play With Pfizer's $100B Bid for AstraZeneca
Morning Money Memo: Deal-making in the pharmaceutical and health care industries is on the rise. The latest example is Pfizer Inc.’s offer to buy British-based AstraZeneca for nearly $100 billion. Astra shares jumped nearly 15 percent today and the company says the Pfizer bid...